News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24
Photo taken from Agenus/LinkedIn
Sep 10, 2024, 13:38

Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24

Agenus shared on LinkedIn:

“The Agenus team is headed to Barcelona for ESMO24.

This Friday, catch the latest data from our clinical trial of botensilimab and balstilimab in refractory sarcomas.

View the presentation details here.”

Proceed to video attached to post.
Source: Agenus/LinkedIn

Agenus Balstilimab botensilimab cancer ESMO ESMO24 OncoDaily Oncology refractory sarcomas
Special Coverage
Societies
Sep 10, 2024, 13:45
Rami Manochakian's key highlights from WCLC24
Societies
Sep 10, 2024, 13:44
There is still time to register for ESMO24
Insight
Sep 10, 2024, 13:43
Douglas Flora: Olalekan Ajayi is joining the AI in Precision Oncology Editorial Board
Blog
Sep 10, 2024, 13:42
Vivek Subbiah: A morning walk to support melanoma research
Insight
Sep 10, 2024, 13:42
Ramandeep Arora's symposium on ‘Patient Tracking as a Tool to Reduce Treatment Abandonment in LMICS’
Blog
Sep 10, 2024, 13:41
Wafik S. El-Deiry: Looking forward to upcoming Legorreta Cancer Center Annual Membership Retreat
Insight
Sep 10, 2024, 13:38
Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24
Insight
Sep 10, 2024, 13:35
Eiffel Tower requested 300,000 USD for lighting the tower for Childhood Cancer Month?
Societies
Sep 10, 2024, 13:32
The Grey Zone for Systemic Therapies in Locally Advanced NSCLC - IASLC
Blog
Sep 10, 2024, 13:22
Joshua Omale: The Global disparity in childhood cancer treatment
Societies
Sep 10, 2024, 13:18
Keeping up with WCLC24 with Eric K. Singhi
Blog
Sep 10, 2024, 13:18
Ana I. Velázquez Mañana: Dr Oscar Arrieta highlights efforts to increase cancer research and cancer care delivery in Mexico and LATAM